Author:
Xu Junnan,Wang Yan,Jiang Cui,Cao Hui,Jiang Junhan,Xu Binghe,Sun Tao
Reference21 articles.
1. Breast cancer statistics, 2019.;DeSantis;CA Cancer J Clin.,2019
2. Breast cancer treatment: a review.;Waks;JAMA.,2019
3. A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer.;Diaby;Breast Cancer Res Treat.,2015
4. Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients.;Zhang;J Hematol Oncol.,2016
5. Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial.;Zhang;Lancet Oncol.,2017
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献